Copyright Reports & Markets. All rights reserved.

Global and Japan Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Monoclonal Antibodies
    • 1.2.3 Small Molecules
    • 1.2.4 Small Molecule Drug Conjugates
  • 1.3 Market by Application
    • 1.3.1 Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Lymphoma
    • 1.3.3 Melanoma
    • 1.3.4 Multiple Myeloma
    • 1.3.5 Breast Cancer
    • 1.3.6 Prostate Cancer
    • 1.3.7 Other Cancers
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2015-2026)
  • 2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Regions
    • 2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Market Size
    • 3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
  • 3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
    • 3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2019
  • 3.5 Key Players Small Molecule Targeted Cancer Therapy Area Served
  • 3.6 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
  • 3.7 Date of Enter into Small Molecule Targeted Cancer Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type (2015-2026)

  • 4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2021-2026)

5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2015-2020)
  • 5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
  • 6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
  • 6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
  • 6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
  • 7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
  • 7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
  • 7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
  • 8.2 China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
  • 8.3 China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
  • 8.4 China Small Molecule Targeted Cancer Therapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
  • 9.2 Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
  • 9.3 Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
  • 9.4 Japan Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
  • 10.2 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 OncoGenex Pharmaceuticals, Inc.
    • 11.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
    • 11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
    • 11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
    • 11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020))
    • 11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
  • 11.2 Cytokinetics Inc.
    • 11.2.1 Cytokinetics Inc. Company Details
    • 11.2.2 Cytokinetics Inc. Business Overview
    • 11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
    • 11.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
    • 11.2.5 Cytokinetics Inc. Recent Development
  • 11.3 Hospira Inc.
    • 11.3.1 Hospira Inc. Company Details
    • 11.3.2 Hospira Inc. Business Overview
    • 11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
    • 11.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
    • 11.3.5 Hospira Inc. Recent Development
  • 11.4 GlaxoSmithKline plc
    • 11.4.1 GlaxoSmithKline plc Company Details
    • 11.4.2 GlaxoSmithKline plc Business Overview
    • 11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
    • 11.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
    • 11.4.5 GlaxoSmithKline plc Recent Development
  • 11.5 Boehringer Ingelheim GmbH
    • 11.5.1 Boehringer Ingelheim GmbH Company Details
    • 11.5.2 Boehringer Ingelheim GmbH Business Overview
    • 11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
    • 11.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
    • 11.5.5 Boehringer Ingelheim GmbH Recent Development
  • 11.6 Bayer HealthCare AG
    • 11.6.1 Bayer HealthCare AG Company Details
    • 11.6.2 Bayer HealthCare AG Business Overview
    • 11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
    • 11.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
    • 11.6.5 Bayer HealthCare AG Recent Development
  • 11.7 Abbott Laboratories
    • 11.7.1 Abbott Laboratories Company Details
    • 11.7.2 Abbott Laboratories Business Overview
    • 11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
    • 11.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
    • 11.7.5 Abbott Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Small Molecule Targeted Cancer Therapy Scope and Market Size
    Small Molecule Targeted Cancer Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targeted Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Monoclonal Antibodies
    Small Molecules
    Small Molecule Drug Conjugates

    Market segment by Application, split into
    Lymphoma
    Melanoma
    Multiple Myeloma
    Breast Cancer
    Prostate Cancer
    Other Cancers

    Based on regional and country-level analysis, the Small Molecule Targeted Cancer Therapy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Small Molecule Targeted Cancer Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    OncoGenex Pharmaceuticals, Inc.
    Cytokinetics Inc.
    Hospira Inc.
    GlaxoSmithKline plc
    Boehringer Ingelheim GmbH
    Bayer HealthCare AG
    Abbott Laboratories
    ...

    Buy now